Cannabinoid–Opioid Cross-Talk Does Not Establish the Same Interaction for Every Outcome

Cannabinoid and opioid systems interact, but evidence for one outcome cannot establish the same interaction for cognition, emotion, withdrawal and relapse. A 2008 review described an uneven evidence base across those domains, including important limits on bidirectional cross-tolerance claims.

Biological overlap is a starting point

The review summarized anatomical, biochemical and molecular evidence linking the two systems. Such overlap makes an interaction plausible, but the behavioral conclusion still depends on the response tested. A pain-related interaction does not quantify a memory effect, and a withdrawal finding does not independently demonstrate a change in relapse risk.

Reciprocity was better established for some questions

The authors described reciprocal interactions in physical dependence as well established within the literature they reviewed. Cross-tolerance and cross-sensitization also had support, but were not always bidirectional. That means prior exposure to one drug changing response to another does not establish that reversing the exposure order produces the same result. The direction of the experimental comparison belongs in the conclusion.

Cognition and emotion had a different evidence gap

The review reported less evidence concerning cognitive and emotional interactions than for several other responses. Advances in craving and relapse research did not fill every one of those gaps. These were synthesis-level observations about the literature available in 2008, rather than a new clinical experiment or a current quantitative estimate of risk for a particular drug combination.

Interpreting the evidence

For a cross-talk claim, name the outcome, exposure order and evidence type. The review supports a network of interactions with different levels of support, rather than one interchangeable cannabinoid–opioid effect or a general clinical benefit from combining the drugs.

Related reading: a separate THC and opioid-withdrawal experiment.

Research reference

Robledo P; Berrendero F; Ozaita A; Maldonado R (2008). Advances in the field of cannabinoid–opioid cross-talk. Addiction biology. doi:10.1111/j.1369-1600.2008.00107.x. Evidence basis: review abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

How Did a Laboratory Study Decide That a Detected Drug Was Non-Prescribed?

A laboratory can identify a drug while relying on outside information to classify its prescription status. A national urine-testing study combined analytical results with medication information supplied by the ordering clinician. Two information streams McClure and colleagues analyzed 231,228 test-result sets from 144,535 patients tested for both opioids and benzodiazepines….

Spread the love

Read Article: How Did a Laboratory Study Decide That a Detected Drug Was Non-Prescribed?

How Did a Stress-Management Trial Protocol Handle Medication Changes?

When a study evaluates psychological treatment, medication changes can complicate attribution of improvement. The 2017 Seren@ctif protocol described how investigators planned to address this issue in a trial of adjustment disorder with anxiety. The planned comparison Servant and colleagues proposed three randomized groups receiving computer-based stress management, an equivalent face-to-face…

Spread the love

Read Article: How Did a Stress-Management Trial Protocol Handle Medication Changes?

What Evidence Supports Extending Lipid Rescue to a Different Poison?

A treatment that appears useful for one toxicant raises a separate scientific question when proposed for another. Eisenkraft and Falk’s 2016 review of lipid emulsion and chemical-agent poisoning provides an example of that evidence gap. Several evidence types The authors discussed proposed lipid-scavenging, metabolic, and cardiovascular mechanisms. They reviewed laboratory…

Spread the love

Read Article: What Evidence Supports Extending Lipid Rescue to a Different Poison?

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us